​
​

Theravance Biopharma Ownership | Who Owns Theravance Biopharma?

OverviewForecastRevenueFinancialsChartTranscripts

Theravance Biopharma Ownership Summary

Theravance Biopharma is owned by 97.57% institutional investors, 5.96% insiders. Madison avenue partners, lp is the largest institutional shareholder, holding 17.63% of TBPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.19% of its assets in Theravance Biopharma shares.

TBPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTheravance Biopharma97.57%5.96%-3.54%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.08M2.19%767.00
Pictet Biopharmaceutical Mother1.00M2.05%-21.29K
iShares Russell 2000 ETF948.99K1.94%-2.13K
Vanguard Institutional Extnd Mkt Idx Tr567.64K1.16%13.74K
State St Russell Sm/Mid Cp® Indx NL Cl C375.78K0.77%-7.60K
Fidelity Small Cap Index373.75K0.76%-9.20K
CREF Stock R1369.86K0.76%-59.19K
iShares Russell 2000 Value ETF344.27K0.70%-
iShares Biotechnology ETF317.74K0.65%-1.90K
Delaware Healthcare I208.78K0.43%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 11, 2024Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$36.00K
Jul 10, 2024Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$36.00K
May 01, 2024Samaha Eli-Buy$8.75M
May 01, 2024Samaha Eli-Buy$4.37M
Feb 22, 2024Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$10.92K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q22-
2024 Q1-1
2023 Q4-3

TBPH Ownership FAQ

Who Owns Theravance Biopharma?

Theravance Biopharma shareholders are primarily institutional investors at 97.57%, followed by 5.96% insiders and -3.53% retail investors. The average institutional ownership in Theravance Biopharma's industry, Biotech Stocks , is 45.35%, which Theravance Biopharma exceeds.

Who owns the most shares of Theravance Biopharma?

Theravance Biopharma’s largest shareholders are Madison avenue partners, lp (8.51M shares, 17.63%), Weiss asset management lp (7.46M shares, 15.44%), and Blackrock (3.78M shares, 7.83%). Together, they hold 40.90% of Theravance Biopharma’s total shares outstanding.

Does Blackrock own Theravance Biopharma?

Yes, BlackRock owns 7.83% of Theravance Biopharma, totaling 3.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.06M$. In the last quarter, BlackRock decreased its holdings by -428K shares, a -10.17% change.

Who is Theravance Biopharma’s biggest shareholder by percentage of total assets invested?

Madison avenue partners, lp is Theravance Biopharma’s biggest shareholder by percentage of total assets invested, with 9.12% of its assets in 8.51M Theravance Biopharma shares, valued at 72.18M$.

Who is the top mutual fund holder of Theravance Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Theravance Biopharma shares, with 2.19% of its total shares outstanding invested in 1.08M Theravance Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools